Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
23.87
-0.13 (-0.52%)
Sep 14, 2026, 3:06 PM EDT - Market open
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $777.56 million as of September 14, 2026. Its market cap has increased by 395.85% in one year.
Market Cap
777.56M
Enterprise Value
755.40M
1-Year Change
395.85%
Ranking
Category
Stock Price
$23.87
ChartMarket Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $777.56M, an increase of 1,240.49%. That is a compound annual growth rate of 75.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 777.56M | 302.06% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 830.77M |
| Climb Bio | 818.47M |
| Candel Therapeutics | 806.89M |
| Silence Therapeutics | 783.93M |
| Aclaris Therapeutics | 783.10M |
| Pharming Group | 761.51M |
| Annexon | 746.94M |
| Monopar Therapeutics | 740.08M |